Ultra-short-acting cardioselective β1 blocker — esterase-mediated hydrolysis gives ~9 min half-life. IV-only; titratable for acute hypertensive emergencies, intraoperative tachycardia, AF rate control where rapid offset is needed.
Half-Life & Elimination Curve (IV: 9m)
Elimination (IV)
0×t½0h100%(0.42 µg/L)
1×t½9m50%(0.21 µg/L)
2×t½18m25%(0.105 µg/L)
3×t½27m12.5%(0.0525 µg/L)
4×t½36m6.3%(0.0263 µg/L)
5×t½45m3.1%(0.0131 µg/L)
Elimination t½9m (IV)
Rate Constant (ke)4.62 h⁻¹
Est. Peak (Cmax)0.42 µg/L
Clearance (CL)1100 L/h
97% Washout (5×t½)45m
Dosing Guidelines
Intravenous (IV): Typical 100 mcg (Range: 50–300 mcg)
Pharmacokinetic Parameters
Intravenous (IV): Bioavailability (F): 100% · Volume of Distribution (Vd): 238 L [PMID 2563962]